drugset / Trial / NCT00149058
Erythropoietin in Acute Myocardial Infarction
RandomizedParallel-groupDouble-blindTreatment
Summary
Erythropoietin (EPO) is a naturally occuring hormone which regulates the body's response to lack of oxygen and controls the number of red cells in the blood. Recent studies in animals have shown that EPO has protective effects when organs such as the heart and brain are injured by lack of oxygen due to reduced blood supply. We wish to test the idea that giving a patient, who is having a heart attack, an injection of EPO will reduce the size of the heart attack.
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 67000 iu | Intravenous |